Long-term engraftment of bone marrow-derived cells in the intimal hyperplasia lesion of autologous vein grafts

Yanpeng Diao, Steve Guthrie, Shen Ling Xia, Xiaosen Ouyang, Li Zhang, Jing Xue, Pui Lee, Maria Grant, Edward Scott, Mark S. Segal

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Intimal hyperplasia of autologous vein grafts is a critical problem affecting the long-term patency of many types of vascular reconstruction. Within intimal hyperplasia lesions, smooth muscle cells are a major component, playing an essential role in the pathological process. Given that bone marrow-derived cells may differentiate into smooth muscle cells in the neointima of injured arteries, we hypothesized that the bone marrow may serve as a source for some of the smooth muscle cells within intimal hyperplasia lesions of vein grafts. To test this hypothesis, we used an established mouse model for intimal hyperplasia in wild-type mice that had been transplanted with bone marrow from a green fluorescent protein (GFP+/+) transgenic mouse. High-resolution confocal microscopy analysis performed 2 and 8 weeks after grafting demonstrated expression of GFP in 5.4 ± 0.8% and 11.9 ± 2.3%, respectively, of smooth muscle cells within intimal hyperplasia lesions. By 16 weeks, GFP expression in smooth muscle cells was not detected by immunohistochemistry; however, real-time PCR revealed that 20.2 ± 1.7% of the smooth muscle cells captured from the neointima lesion by laser capture microdissection at 16 weeks contained GFP DNA. Our results suggest that bone marrow-derived cells differentiated into smooth muscle cells within the intimal lesion and may provide a novel clinical approach for decreasing intimal hyperplasia in vein grafts.

Original languageEnglish (US)
Pages (from-to)839-848
Number of pages10
JournalAmerican Journal of Pathology
Volume172
Issue number3
DOIs
StatePublished - Mar 2008
Externally publishedYes

Fingerprint

Tunica Intima
Bone Marrow Cells
Smooth Muscle Myocytes
Hyperplasia
Veins
Transplants
Neointima
Vascular Patency
Bone Marrow
Laser Capture Microdissection
Pathologic Processes
Green Fluorescent Proteins
Confocal Microscopy
Transgenic Mice
Real-Time Polymerase Chain Reaction
Arteries
Immunohistochemistry
DNA

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Long-term engraftment of bone marrow-derived cells in the intimal hyperplasia lesion of autologous vein grafts. / Diao, Yanpeng; Guthrie, Steve; Xia, Shen Ling; Ouyang, Xiaosen; Zhang, Li; Xue, Jing; Lee, Pui; Grant, Maria; Scott, Edward; Segal, Mark S.

In: American Journal of Pathology, Vol. 172, No. 3, 03.2008, p. 839-848.

Research output: Contribution to journalArticle

Diao, Y, Guthrie, S, Xia, SL, Ouyang, X, Zhang, L, Xue, J, Lee, P, Grant, M, Scott, E & Segal, MS 2008, 'Long-term engraftment of bone marrow-derived cells in the intimal hyperplasia lesion of autologous vein grafts', American Journal of Pathology, vol. 172, no. 3, pp. 839-848. https://doi.org/10.2353/ajpath.2008.070840
Diao, Yanpeng ; Guthrie, Steve ; Xia, Shen Ling ; Ouyang, Xiaosen ; Zhang, Li ; Xue, Jing ; Lee, Pui ; Grant, Maria ; Scott, Edward ; Segal, Mark S. / Long-term engraftment of bone marrow-derived cells in the intimal hyperplasia lesion of autologous vein grafts. In: American Journal of Pathology. 2008 ; Vol. 172, No. 3. pp. 839-848.
@article{0e5f1049dc5c44979ca427c570738cf8,
title = "Long-term engraftment of bone marrow-derived cells in the intimal hyperplasia lesion of autologous vein grafts",
abstract = "Intimal hyperplasia of autologous vein grafts is a critical problem affecting the long-term patency of many types of vascular reconstruction. Within intimal hyperplasia lesions, smooth muscle cells are a major component, playing an essential role in the pathological process. Given that bone marrow-derived cells may differentiate into smooth muscle cells in the neointima of injured arteries, we hypothesized that the bone marrow may serve as a source for some of the smooth muscle cells within intimal hyperplasia lesions of vein grafts. To test this hypothesis, we used an established mouse model for intimal hyperplasia in wild-type mice that had been transplanted with bone marrow from a green fluorescent protein (GFP+/+) transgenic mouse. High-resolution confocal microscopy analysis performed 2 and 8 weeks after grafting demonstrated expression of GFP in 5.4 ± 0.8{\%} and 11.9 ± 2.3{\%}, respectively, of smooth muscle cells within intimal hyperplasia lesions. By 16 weeks, GFP expression in smooth muscle cells was not detected by immunohistochemistry; however, real-time PCR revealed that 20.2 ± 1.7{\%} of the smooth muscle cells captured from the neointima lesion by laser capture microdissection at 16 weeks contained GFP DNA. Our results suggest that bone marrow-derived cells differentiated into smooth muscle cells within the intimal lesion and may provide a novel clinical approach for decreasing intimal hyperplasia in vein grafts.",
author = "Yanpeng Diao and Steve Guthrie and Xia, {Shen Ling} and Xiaosen Ouyang and Li Zhang and Jing Xue and Pui Lee and Maria Grant and Edward Scott and Segal, {Mark S.}",
year = "2008",
month = "3",
doi = "10.2353/ajpath.2008.070840",
language = "English (US)",
volume = "172",
pages = "839--848",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Long-term engraftment of bone marrow-derived cells in the intimal hyperplasia lesion of autologous vein grafts

AU - Diao, Yanpeng

AU - Guthrie, Steve

AU - Xia, Shen Ling

AU - Ouyang, Xiaosen

AU - Zhang, Li

AU - Xue, Jing

AU - Lee, Pui

AU - Grant, Maria

AU - Scott, Edward

AU - Segal, Mark S.

PY - 2008/3

Y1 - 2008/3

N2 - Intimal hyperplasia of autologous vein grafts is a critical problem affecting the long-term patency of many types of vascular reconstruction. Within intimal hyperplasia lesions, smooth muscle cells are a major component, playing an essential role in the pathological process. Given that bone marrow-derived cells may differentiate into smooth muscle cells in the neointima of injured arteries, we hypothesized that the bone marrow may serve as a source for some of the smooth muscle cells within intimal hyperplasia lesions of vein grafts. To test this hypothesis, we used an established mouse model for intimal hyperplasia in wild-type mice that had been transplanted with bone marrow from a green fluorescent protein (GFP+/+) transgenic mouse. High-resolution confocal microscopy analysis performed 2 and 8 weeks after grafting demonstrated expression of GFP in 5.4 ± 0.8% and 11.9 ± 2.3%, respectively, of smooth muscle cells within intimal hyperplasia lesions. By 16 weeks, GFP expression in smooth muscle cells was not detected by immunohistochemistry; however, real-time PCR revealed that 20.2 ± 1.7% of the smooth muscle cells captured from the neointima lesion by laser capture microdissection at 16 weeks contained GFP DNA. Our results suggest that bone marrow-derived cells differentiated into smooth muscle cells within the intimal lesion and may provide a novel clinical approach for decreasing intimal hyperplasia in vein grafts.

AB - Intimal hyperplasia of autologous vein grafts is a critical problem affecting the long-term patency of many types of vascular reconstruction. Within intimal hyperplasia lesions, smooth muscle cells are a major component, playing an essential role in the pathological process. Given that bone marrow-derived cells may differentiate into smooth muscle cells in the neointima of injured arteries, we hypothesized that the bone marrow may serve as a source for some of the smooth muscle cells within intimal hyperplasia lesions of vein grafts. To test this hypothesis, we used an established mouse model for intimal hyperplasia in wild-type mice that had been transplanted with bone marrow from a green fluorescent protein (GFP+/+) transgenic mouse. High-resolution confocal microscopy analysis performed 2 and 8 weeks after grafting demonstrated expression of GFP in 5.4 ± 0.8% and 11.9 ± 2.3%, respectively, of smooth muscle cells within intimal hyperplasia lesions. By 16 weeks, GFP expression in smooth muscle cells was not detected by immunohistochemistry; however, real-time PCR revealed that 20.2 ± 1.7% of the smooth muscle cells captured from the neointima lesion by laser capture microdissection at 16 weeks contained GFP DNA. Our results suggest that bone marrow-derived cells differentiated into smooth muscle cells within the intimal lesion and may provide a novel clinical approach for decreasing intimal hyperplasia in vein grafts.

UR - http://www.scopus.com/inward/record.url?scp=40449111345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40449111345&partnerID=8YFLogxK

U2 - 10.2353/ajpath.2008.070840

DO - 10.2353/ajpath.2008.070840

M3 - Article

C2 - 18276778

AN - SCOPUS:40449111345

VL - 172

SP - 839

EP - 848

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 3

ER -